Biotech & MedTech
-
FendX Technologies’ Dr Carolyn Myers Provides REPELWRAP Film Manufacturing Dunmore Partnership Update
In a recent interview with Tracy Weslosky, Dr. Carolyn Myers, President, CEO, and Director of FendX Technologies Inc.…
-
Coeptis Therapeutics’ Dave Mehalick on the disruptive potential of SNAP-CAR technology for autoimmune diseases
In an insightful interview with Tracy Weslosky, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc.…
-
Greg Fenton Discusses Zentek’s 2024 Progress and Exclusive Aptamer Technology Rights
In a detailed interview with Tracy Weslosky, Greg Fenton, CEO and Director of Zentek Ltd. (NASDAQ: ZTEK |…
-
Dr. Colleen Delaney from Coeptis Therapeutics on the development of next-generation cell therapy technologies for cancer and infectious diseases
In a recent Investor.Coffee interview with host Jack Lifton, Dr. Colleen Delaney, Chief Scientific and Medical Officer at…
-
Coeptis CEO Dave Mehalick on NASDAQ listing and entering the Cancer Treatment Race
Innovative cell therapy platforms have the potential to disrupt conventional cancer treatment In an InvestorCoffee interview with host…
-
Andre Larente from DIAGNOS on Deal with World’s Largest Eyecare Retailer EssilorLuxottica
InvestorNews host Tracy Weslosky recently conducted an insightful interview with André Larente, President and Director of DIAGNOS Inc.…
-
Investor.Coffee (12.11.2023): CDN Healthcare Deal, U.S. Dollar Gains Strength on Japan’s Nikkei Rebound
DIAGNOS Inc. (TSXV: ADK | OTCQB: DGNOF), a company we have followed for several years out of Montreal, announced…
-
Dr. Carolyn Myers on FendX Technologies’ Breakthrough Film Formulation that Kills and Repels Bacteria
In an insightful interview with Tracy Weslosky from Investor.Coffee, Dr. Carolyn Myers, President, CEO, and Director of FendX…
-
Greg Fenton on how Zentek’s Advancement in Aptamer Technology is Revolutionizing Biotech
In an interview with host Tracy Weslosky from InvestorNews, Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO Greg…
-
Progress in Pathogen Defense, Dr. Carolyn Myers Discusses FendX’s Collaboration with Dunmore for REPELWRAP™
In a recent interview with InvestorNews host Tracy Weslosky, FendX Technologies Inc.’s (CSE: FNDX | OTCQB: FDXTF) President, CEO,…
